Its not a replacement for hormonal or other treatments when theyre warranted, but its a meaningful complement
However, if these clinicians, separately, provide and bill for services under the Physician Fee Schedule, they would be required to participate in ASM provided they meet the ASM participant eligibility criteria
44 Antigenantibody ICs: a double-edged sword Antigenantibody ICs can either cause immune pathological effects or potentiate beneficial immune effects, depending on various factors, including the subclasses of the antibody, the ratio between the antigen and the antibody forming the IC, the biological characteristics of the IC components, the sites where the ICs were formed, the cells involved and how the ICs were introduced into hosts etc
[DOI] [PMC free article] [PubMed] [Google Scholar] 2.Fukushima Y, Ohie T, Yonekawa Y, Yonemoto K, Aizawa H, Mori Y, Watanabe M, Takeuchi M, Hasegawa M, Taguchi C, Kondo K
Several Nrf2 activators have now entered clinical trials, but further research is needed to investigate their long-term efficacy and safety